Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−16.65 MXN
−9.49 B MXN
269.18 B MXN
1.13 B
About TEVA
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
T
TEVA.GJ
Teva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026Yield to maturity
8.75%
Maturity date
Feb 1, 2026
T
TEVA5034099
Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025Yield to maturity
7.91%
Maturity date
Jan 31, 2025
T
TEVA4608603
Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028Yield to maturity
6.96%
Maturity date
Mar 1, 2028
T
TEVA4914602
Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025Yield to maturity
6.44%
Maturity date
Jan 31, 2025
T
TEVA5295244
Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027Yield to maturity
5.80%
Maturity date
May 9, 2027
T
TEVA5295245
Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029Yield to maturity
5.69%
Maturity date
May 9, 2029
T
TEVA4608604
Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028Yield to maturity
5.61%
Maturity date
Mar 1, 2028
T
TEVA5549923
Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029Yield to maturity
5.59%
Maturity date
Sep 15, 2029
Explore more bonds
Frequently Asked Questions
The current price of TEVA/N is 339.00 MXN — it has decreased by −2.31% in the past 24 hours. Watch TEVA PHARMACEUTICAL INDUSTRIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange TEVA PHARMACEUTICAL INDUSTRIES stocks are traded under the ticker TEVA/N.
TEVA/N stock has fallen by −2.31% compared to the previous week, the month change is a −9.36% fall, over the last year TEVA PHARMACEUTICAL INDUSTRIES has showed a 100.59% increase.
We've gathered analysts' opinions on TEVA PHARMACEUTICAL INDUSTRIES future price: according to them, TEVA/N price has a max estimate of 529.73 MXN and a min estimate of 366.73 MXN. Watch TEVA/N chart and read a more detailed TEVA PHARMACEUTICAL INDUSTRIES stock forecast: see what analysts think of TEVA PHARMACEUTICAL INDUSTRIES and suggest that you do with its stocks.
TEVA/N reached its all-time high on Aug 5, 2015 with the price of 1,162.48 MXN, and its all-time low was 120.96 MXN and was reached on Aug 16, 2019. View more price dynamics on TEVA/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TEVA/N stock is 2.36% volatile and has beta coefficient of 0.53. Track TEVA PHARMACEUTICAL INDUSTRIES stock price on the chart and check out the list of the most volatile stocks — is TEVA PHARMACEUTICAL INDUSTRIES there?
Today TEVA PHARMACEUTICAL INDUSTRIES has the market capitalization of 384.02 B, it has increased by 5.66% over the last week.
Yes, you can track TEVA PHARMACEUTICAL INDUSTRIES financials in yearly and quarterly reports right on TradingView.
TEVA PHARMACEUTICAL INDUSTRIES is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
TEVA/N earnings for the last quarter are 13.60 MXN per share, whereas the estimation was 13.03 MXN resulting in a 4.35% surprise. The estimated earnings for the next quarter are 14.06 MXN per share. See more details about TEVA PHARMACEUTICAL INDUSTRIES earnings.
TEVA PHARMACEUTICAL INDUSTRIES revenue for the last quarter amounts to 85.36 B MXN, despite the estimated figure of 81.56 B MXN. In the next quarter, revenue is expected to reach 83.25 B MXN.
TEVA/N net income for the last quarter is −8.61 B MXN, while the quarter before that showed −15.50 B MXN of net income which accounts for 44.44% change. Track more TEVA PHARMACEUTICAL INDUSTRIES financial stats to get the full picture.
No, TEVA/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 4, 2024, the company has 37.23 K employees. See our rating of the largest employees — is TEVA PHARMACEUTICAL INDUSTRIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TEVA PHARMACEUTICAL INDUSTRIES EBITDA is 95.17 B MXN, and current EBITDA margin is 27.45%. See more stats in TEVA PHARMACEUTICAL INDUSTRIES financial statements.
Like other stocks, TEVA/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TEVA PHARMACEUTICAL INDUSTRIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TEVA PHARMACEUTICAL INDUSTRIES technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TEVA PHARMACEUTICAL INDUSTRIES stock shows the buy signal. See more of TEVA PHARMACEUTICAL INDUSTRIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.